Summary The growth inhibitory effects of all-trans and 13-cis retinoic acid (RA) and of the synthetic retinoids TTNPB, TTNPB-ethylester and TTNN were studied on seven human epithelial ovarian cancer cell lines and one ovarian teratocarcinoma cell line. Six of seven ovarian adenocarcinoma cell lines were inhibited in their growth by RA and by synthetic retinoids in a dose dependent manner. No response to these substances was observed for the ovarian teratocarcinoma cell line. The knowledge that RA and retinoids exert their action on the cells via nuclear receptors led us to examine the expression of RAR-a, -,B and -mRNA by these cell lines by polymerase chain reaction following reverse transcription. All cell lines expressed RAR-x and -mRNA and six of the eight cell lines were found to express additionally RAR-P mRNA, among them the ovarian teratocarcinoma cell line. Our data indicate that there was no direct association between the presence of RAR subtype transcripts and the response to retinoids in ovarian cancer cell lines.
Retinoic acid (RA) is a morphogenic compound involved in vertebrate development (Eichele, 1989 ) and it plays a major role in epithelial cell growth and cellular differentiation (Sporn et al., 1984) . RA induces differentiation of mouse embryonal carcinoma cells in vitro and influences the development of the regenerating amphibian limb (for review see de Luca, 1991) .
It has also been shown that retinoids cause growth inhibition in many hyperproliferating cell lines, a feature that makes the compounds of fundamental interest as antitumour agents. Retinoids prevent the development of cancer of the skin and are effective as agents in the treatment of human premalignant and malignant cutaneous disorders (Lippman & Meyskens, 1989) . In addition, retinoids are successfully used in the therapy of the acute promyelocytic leukaemia (Meng-er et al., 1988) .
Several intracellular proteins interacting with RA have been identified, such as the cellular retinoic acid binding protein (CRABP) and the nuclear retinoic acid receptors (RARs) . Three RAR subtypes RAR-a, -P and -y have been identified so far (Petkovich et al., 1987; Giguere et al., 1987; Benbrook et al., 1988; Brand et al., 1988; Krust et al., 1989) . The RARs belong to the family of steroid-and thyroid hormone receptors and act as transcriptional enhancer factors. The binding of RARs to specific response elements leads to self-modulation of their transcription (Umesono et al., 1988; Glass et al., 1989; de The et al., 1990) . In addition, another subfamily of nuclear receptors (termed RXRs) which might mediate some of the effects of RA or its different metabolites, has been described (Mangelsdorf et al., 1990; Yu et al., 1991; Heyman et al., 1992) . It has also been shown that RA and synthetic retinoids have different receptor affinities and each receptor has a different potency in stimulating transcription of target genes (Astrom et al., 1990; Graupner et al., 1991; Delelcuse et al., 1991) . Nevertheless, the exact mechanism of action by which RA and retinoids work is still to be elucidated.
In this report we studied the effects of RA and synthetic retinoids on the growth of several human ovarian cancer cell lines in vitro and the expression of RAR-xo, -P and -v mRNA in these cell lines, both without and with exposition to RA.
Materials and methods

Cell culture
The ovarian adenocarcinoma cell lines HOC-7 and HEY were a generous gift from Dr R. Buick (Gibco, Scotland) and were maintained in an humidified 5% CO2 atmosphere at 37°C. Cultures were refed after 4 days and passaged weekly 1:5 -1:10.
All cells were used within 30 passages from the original stock.
Tests for mycoplasma contamination were negative (DAPI, Boehringer Mannheim, Germany).
Retinoids
All-trans RA, 1 3-cis RA, (E)-4- [2-(5,6,7,8-tetrahydro-5,5,8,8,-tetramethyl-2-naphthalenyl)-1-propenyl] benzoic acid -(5,6,7,8-tetrahydro-5,5,8,8,-tetramethyl-2- RNA isolation and reverse transcription Total cellular RNA was isolated by the guanidinium isothiocyanate procedure (Chomczynski & Sacchi, 1987 RAR-P sense 5'-AGGAGACTTCGAAGCAAG-3', antisense 5'-GTCAAGGGTTCATGTCCTTC-3'; RAR-y sense 5'-GGAAGAAGGGTCACCTGA-3', antisense 5'-CGGCGCCGGGCGTACAGC-3'. Primer sequences were as follows:
A TG C RAR-a, -,, -y sense 5'-CCTCGCTCTGCCAGCTGGG-3'; RAR-a antisense 5'-CTACAGCTGCCTGGCGGG-3'; Figure la . In contrast thereto, only a weak response to RA and to synthetic retinoids was observed for the cell line HOC-7 as illustrated in Figure lb . The human ovarian teratocarcinoma cell line PA-1 was not inhibited in its growth by any of the substances, except by the highest concentration of 13-cis RA tested.
Due to the known growth inhibiting effects of DMSO on proliferating cells a control culture without 0.1% DMSO was used in each experiment. There was no growth reduction exceeding more than 5% of control in the presence of 0.1% DMSO. Analysis of PCR products Total RNA was extracted from eight ovarian carcinoma cell lines. RNAs were transcribed into cDNA and then amplified using gene-specific primer pairs and polymerase chain reaction methodology (Mullis & Faloona, 1987; Saiki et al., 1988) . The identity of the PCR products were confirmed with three methods. First, a primary PCR product was amplified from the target cDNA. The fragment sizes for RAR-x, -P and -y are illustrated in Table I . As negative control total RNA was amplified under the same conditions to investigate whether there was a contamination of chromosomal DNA in the RNA preparation. Due to a minor homology of the three receptor subtypes the primer pairs were located in the ligand binding domain (region E) of the RARs. To confirm these PCR products a semi-nested PCR was used as a second step. For semi-nested PCR one slightly degenerated 5'-primer was used for amplification of all three receptor subtypes due to the high homology in this region. With 3'-primers already used in the first PCR experiment three defined PCR products for RAR-4o, -P and --were amplified as shown in Table I .
Semi-nested PCR products were separated on a 2% agarose gel as shown in Figures 2, 3 and 4. As negative control amplified RNA samples were amplified under the same conditions to confirm whether there were contaminations between the two PCR experiments. In a third step PCR products from the semi-nested experiment were digested with specific restriction endonucleases. The RAR-a PCR product was digested with Aval. Three defined fragments (127, 237 and 371 base pairs) separated on H 134 a 2% agarose gel are shown in Figure 5 . Hinfl was chosen for digestion of the RAR-P PCR product (47, 157 and 468 base pairs) as shown in Figure 6 . BsmAI was used for restriction analysis of the RAR-y PCR product. Three defined fragments (37, 97 and 364 base pairs) separated on a 2% agarose gel are shown in Figure 7 .
Expression of RAR-a, -P and -y mRNA Figure 5 Restriction endonuclease digestion of the RAR-a semi-nested PCR products separated on a 2% agarose gel, stained with ethidiumbromide (fragments: 127, 237 and 371 bp). (1), HEY (2), HI134 (3), 100 bp DNA ladder (4), HTB 77 (5), HTB 75 (6), OVCAR-3 (7), TR 170 (8), 100 bp DNA ladder (9), PA-i (10). The DNA ladder (ordinate) consists of 15 blunt ended fragments between 100 and 1500 base pairs in multiples of 100 bp. addition, these agents have been successfully used in the therapy of squamous cell carcinomas and in the prevention of second primary carcinomas of the aerobronchodigestive tract (Hong et al., 1990; Lippman et al., 1992 (Hamilton et al., 1983; Buick et al., 1985; Hill et al., 1987; Broxtenman et al., 1987) . All epithelial ovarian cancer cell lines were inhibited in their growth by RA and synthetic RA-analogs in a dose dependent manner. The cell lines HTB 77, HTB 75, OVCAR-3 and TR 170 were highly responsive to the retinoids tested, but also the rapidly growing cell lines HEY and especially H134 were inhibited in their growth by retinoids. The ovarian adenocarcinoma cell line HOC-7 had already been used earlier by us as a model for growth inhibition and differentiation induction by polar-planar compounds like Dimethylsulfoxide and N,N'-dimethylformamide as well as by transforming growth factor-PI (TGF-1I) and by all-trans RA. But, all-trans RA caused only a weak growth inhibition and induction of differentiation associated antigens in this cell line (Grunt et al., 1992a (Grunt et al., , 1992b Somay et al., 1992 ). The various retinoids tested in our experiments also yielded only weak growth inhibition in this cell line. The fact that both the slowly growing cell lines and the two rapidly growing cells HEY and H134 were intensively inhibited in their growth by retinoids led us to conclude that the response of the epithelial ovarian cancer cell lines to these agents was not directly dependent on their proliferation capacity. In contrast, the ovarian teratocarcinoma cell line PA-1 exhibited a divergent behaviour when treated with these substances. No growth inhibition, but even a growth promoting effect at nanomolar concentrations of each retinoid tested was observed.
Due to the characterisation of the nuclear RARs a better insight into the mode of action of retinoids on the target cells was gained. RAR-x seems to be distributed ubiquitously in cells and tissues, while the expression of RAR-3 and -y mRNA is tissue-specific (de Luca, 1991) . Abnormal expression of RAR-P mRNA has been reported for some hepatoma cells and in human oral and epidermal squamous cell carcinoma cell lines (Hu et al., 1991) . RAR--mRNA has been shown to be abundantly expressed in the skin (Krust et al., 1989 Graupner et al., 1991) .
The lack of RAR-P mRNA in HOC-7 and OVCAR-3 cells would therefore lead us to expect a similar response of both cell lines to retinoids, but a divergent behaviour to the retinoids tested was observed among the two cell lines. On the other side, the cell line PA-1, which was non-responsive to the retinoids tested expressed mRNAs for all three receptor subtypes. Overall, we could not observe a conclusive association between the presence of RAR subtype transcripts and the response to retinoids in these cell lines. The most striking finding, that there was a lack of RAR-P transcripts in two out of eight cell lines, has to be investigated in the future on the molecular level more in depth. First, by the method of RT-PCR only a qualitative but not a quantitative determination of RAR transcripts could be performed which will be quantified by Northern Analysis and second, rearrangements or deletions in the RAR-P gene or other mutational events may be suspected to be the underlaying mechanism for the observed lack of RAR-P mRNA expression and will be the target of further investigations (Pratt et al., 1990; Hu et al., 1991) . We conclude that RA and synthetic retinoids are potent substances to induce growth inhibition in ovarian cancer cells. In continuation to these studies the determination of differentiation associated parameters in retinoid treated ovarian cancer cells to distinguish between growth inhibition and differentiation induction and the use of retinoids in combination with other substances in order to increase their differentiation capacity are planned.
